1 조혜영, "뉴론틴 캡슐 300밀리그람(가바펜틴 300�mg)에 대한 건일가바펜틴 캡슐300밀리그람의 생물학적동등성" 한국약제학회 35 (35): 193-199, 2005
2 S. Frances, "The use of citric acid to prolong the in vivo gastro retention of floating dosage form in the fasted state" 308 : 8-13, 2006
3 M. Oth, "The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol" 9 : 298-302, 1992
4 Y.D. Tang, "Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form" 336 : 159-165, 2007
5 A. Amin, "Progress in swellable & low density excipients for prolonged gastric retention" 22-26, 2008
6 L. Meka, "Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: In vitro evaluation" 9 (9): 612-618, 2008
7 T. Gordi, "Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive–extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, tree-way crossover, exploratory study in healthy subjects" 300 (300): 909-916, 2008
8 E.A. Klausner, "Novel levodopa gastroretentive dosage form: invivo evaluation in dogs" 88 : 117-126, 2003
9 A. Streuble, "Gastroretentive drug delivery systems" 3 (3): 217-233, 2006
10 T. Gordi, "Gabapentin pharmacokinetics after the administration of a gastric retentive formulation in postmenopausal women with hot flashes, Abstracts No. 1839" 2008
1 조혜영, "뉴론틴 캡슐 300밀리그람(가바펜틴 300�mg)에 대한 건일가바펜틴 캡슐300밀리그람의 생물학적동등성" 한국약제학회 35 (35): 193-199, 2005
2 S. Frances, "The use of citric acid to prolong the in vivo gastro retention of floating dosage form in the fasted state" 308 : 8-13, 2006
3 M. Oth, "The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol" 9 : 298-302, 1992
4 Y.D. Tang, "Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form" 336 : 159-165, 2007
5 A. Amin, "Progress in swellable & low density excipients for prolonged gastric retention" 22-26, 2008
6 L. Meka, "Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: In vitro evaluation" 9 (9): 612-618, 2008
7 T. Gordi, "Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive–extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, tree-way crossover, exploratory study in healthy subjects" 300 (300): 909-916, 2008
8 E.A. Klausner, "Novel levodopa gastroretentive dosage form: invivo evaluation in dogs" 88 : 117-126, 2003
9 A. Streuble, "Gastroretentive drug delivery systems" 3 (3): 217-233, 2006
10 T. Gordi, "Gabapentin pharmacokinetics after the administration of a gastric retentive formulation in postmenopausal women with hot flashes, Abstracts No. 1839" 2008
11 B.N. Singh, "Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention" 63 : 235-259, 2000
12 E.A. Klausner, "Expandable gastroretentive dosage form" 90 : 142-162, 2003
13 V. Cowles, "Dose Proportionality of Gabapentin Gastric Retentive Extended-Release Tablets in Beagle Dog, Abstracts No. 2109" 2006
14 M. Chavanpatil, "Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation" 304 : 178-184, 2005
15 A.A. Deshpande, "Controlled-release drug delivery systems for prolonged gastric residence" 22 (22): 531-539, 1996
16 S.S. Ahmed, "Bioavailability of riboflavin from a gastric retention formulation" 330 : 146-154, 2007
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
ScienceON
KISS
